BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 18343412)

  • 1. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
    Stewart CS; Leibovich BC; Weaver AL; Lieber MM
    J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.
    Jones JS; Patel A; Schoenfield L; Rabets JC; Zippe CD; Magi-Galluzzi C
    J Urol; 2006 Feb; 175(2):485-8. PubMed ID: 16406977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is race a positive predictor of cancer on repeat prostate biopsy?
    Yanke BV; Salzhauer EW; Colon I
    J Urol; 2006 Sep; 176(3):1114-7. PubMed ID: 16890704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy.
    Eggener SE; Roehl KA; Catalona WJ
    J Urol; 2005 Aug; 174(2):500-4. PubMed ID: 16006880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
    Ploussard G; Dubosq F; Boublil V; Allory Y; de la Taille A; Vordos D; Hoznek A; Abbou CC; Salomon L
    J Urol; 2009 Oct; 182(4):1342-9. PubMed ID: 19683310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y; Ayala AG; Tamboli P; Babaian RJ
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 May; 177(5):1749-52. PubMed ID: 17437804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
    Pepe P; Aragona F
    Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of extended pattern technique for initial prostate biopsy.
    Siu W; Dunn RL; Shah RB; Wei JT
    J Urol; 2005 Aug; 174(2):505-9. PubMed ID: 16006881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population.
    Rabets JC; Jones JS; Patel A; Zippe CD
    J Urol; 2004 Jul; 172(1):94-7. PubMed ID: 15201745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in patterns of practice in diagnosing screen-detected prostate cancer.
    Nam RK; Toi A; Trachtenberg J; Jewett MA; Klotz L; Fleshner N; Bagnell PS; Sweet J; Sugar L; Narod SA
    BJU Int; 2004 Dec; 94(9):1239-44. PubMed ID: 15610097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial biopsy results in prostate cancer screening study.
    Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2002 Jun; 167(6):2435-9. PubMed ID: 11992052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates.
    Sajadi KP; Kim T; Terris MK; Brown JA; Lewis RW
    Urology; 2007 Oct; 70(4):691-5. PubMed ID: 17991539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.
    Carter HB; Walsh PC; Landis P; Epstein JI
    J Urol; 2002 Mar; 167(3):1231-4. PubMed ID: 11832703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate biopsy: who, how and when. An update.
    Djavan B; Milani S; Remzi M
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.